Testing version — LOERadar is in active testing. Features and data may change.

TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE) | LOERadar

Viewing data from:

TRAVASOL 2.75% IN DEXTROSE 5% IN PLASTIC CONTAINER

NDA

AMINO ACIDS; DEXTROSE | N019520 | BAXTER HEALTHCARE CORP

10 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 12, 2000	SUPPL -18	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (10)

Sort:

#002 — 2.75%;10GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#003 — 2.75%;15GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#004 — 2.75%;20GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#005 — 2.75%;25GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#001 — 2.75%;5GM/100ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Sep 23, 1988

No patent or exclusivity listings for this strength.

#007 — 4.25%;10GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#008 — 4.25%;15GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#009 — 4.25%;20GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#010 — 4.25%;25GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988

#006 — 4.25%;5GM/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 23, 1988